Maternal age-related differences in the timing of pregnancy loss in a nationwide ART cohort
- 1University of Gothenburg
Abstract
Study questionAre maternal age and a history of previous pregnancy losses associated with the timing of pregnancy loss for women undergoing ART treatment?
Summary answerAmong women who underwent ART treatment, younger women had a higher risk of very early biochemical pregnancy losses. Women with previous pregnancy losses overall experienced pregnancy losses at an earlier gestational age.
What is known alreadyMaternal age and history of pregnancy loss are two of the strongest, independent determinants of pregnancy loss risk.
Study design, size, durationThis retrospective cohort study comprises all embryo transfers in Sweden between 2007 and 2022 (n = 202,008). The Swedish Quality Register for Assisted Reproduction (Q-IVF) provides information on confirmed pregnancies from two weeks after embryo transfer. Additional information was retrieved from the Swedish Medical Birth Register and the National Patient Register.
Participants/materials, setting, methodsWe studied 202,008 embryo transfers resulting in 80,673 biochemically verified pregnancies and 21,240 pregnancy losses. We assessed the associations between two exposures (maternal age and history of pregnancy loss) and four outcomes (implantation failure, pregnancy loss, the proportion of pregnancy losses occurring within the biochemical pregnancy window, and the gestational duration when the pregnancy loss was diagnosed). Fixed and mixed linear and logistic regression models were used, the latter to account for unmeasured confounding shared across pregnancies from the same mothers. Through analyses of subgroups including oocyte recipients (n = 3,558) and women undergoing treatment due to male infertility (n = 41,721), we attempted to tease out the effects of potential unmeasured confounders, such as maternal oocyte aneuploidies.
Main results and the role of chanceMean maternal age was 34 years, 23 % had a history of pregnancy loss, implantation failure occurred after 60 % of embryo transfers and pregnancy loss occurred in 26 % after successful implantation.
Higher maternal age was associated with increased risk of implantation failure (OR = 1.02 per year; 95% CI = 1.02, 1.02), and pregnancy loss after successful implantation (OR = 1.05 per year; 95% CI = 1.05, 1.06). We observed no relationship between maternal age and the risk of implantation failure or pregnancy loss among women undergoing ART with donated oocytes. Among those who experienced pregnancy loss, the proportion of pregnancy losses within the biochemical window decreased with increasing maternal age (OR = 0.94 per year; 95% CI = 0.93, 0.94), a result consistent across all subgroups and regardless of oocyte origin.
The number of previous pregnancy losses was associated with a lower risk of implantation failure (OR = 0.82; 95% CI = 0.81, 0.84), but not with pregnancy loss in the index pregnancy after accounting for within-women correlations using mixed-effects models (OR = 1.02; 95% CI= 0.99, 1.04).
Limitations, reasons for cautionSince all women studied underwent ART treatment, the findings may not apply to naturally conceived pregnancies. The gestational duration of pregnancy losses reflects the time at diagnosis, and thus is an upper bound for the pregnancy loss.
Wider implications of the findingsThis study confirms (oocyte) maternal age and history of pregnancy loss as influential in risk of implantation failure and pregnancy loss, and suggests that maternal age may delay the timing of the pregnancy loss, particularly among pregnancy losses occurring within the biochemical pregnancy window.
Study funding/competing interest(s)Funding for this research project was granted by the Swedish Research Council; the Swedish Society for Medical Research; the Agreement concerning research and education of doctors; FORTE; Swedish Research Council for Health, Working Life and Welfare; the Hjalmar Svensson Foundation; the Research Council of Norway. The authors declare no conflicts of interest.
Trial registration numberN/A
Related
- Ectopic pregnancy-related severe maternal morbidity in Shenzhen: a sentinel indicator for gaps in early pregnancy care systems.
- Maternal body mass index in early pregnancy and offspring mortality up to early adulthood: A nationwide cohort study
- Interocular Differences in Visual Acuity and Refractive Status Between Unilateral Early and Late Age-Related Macular Degeneration: A Nationwide Population-Based Study
- Adverse pregnancy outcomes and associated maternal and infection-related factors in a rural malaria-endemic setting in Western Kenya
- Multi-site metabolomics reveals one-carbon and placental steroid disruption in maternal pre-pregnancy obesity linked to adverse pregnancy outcomes
BibTeX
@misc{evers2026maternal,
title = {{Maternal age-related differences in the timing of pregnancy loss in a nationwide ART cohort}},
author = {F. Evers and K. Ytterberg and A. R. Ramirez-Jimenez and Y. Zhao and P. Nyeboe and M. C. Magnus and J. Juodakis and B. Jacobsson and P. Sole-Navais},
howpublished = {medRxiv},
year = {2026},
month = sep,
doi = {10.64898/2026.09.28.26364171},
url = {https://www.medrxiv.org/content/10.64898/2026.09.28.26364171v1},
note = {CC BY-ND},
}
RIS
TY - UNPB
TI - Maternal age-related differences in the timing of pregnancy loss in a nationwide ART cohort
AU - F. Evers
AU - K. Ytterberg
AU - A. R. Ramirez-Jimenez
AU - Y. Zhao
AU - P. Nyeboe
AU - M. C. Magnus
AU - J. Juodakis
AU - B. Jacobsson
AU - P. Sole-Navais
PY - 2026
DA - 2026/09/28
PB - medRxiv
DO - 10.64898/2026.09.28.26364171
UR - https://www.medrxiv.org/content/10.64898/2026.09.28.26364171v1
AB - Study questionAre maternal age and a history of previous pregnancy losses associated with the timing of pregnancy loss for women undergoing ART treatment? Summary answerAmong women who underwent ART treatment, younger women had a higher risk of very early biochemical pregnancy losses. Women with previous pregnancy losses overall experienced pregnancy losses at an earlier gestational age. What is known alreadyMaternal age and history of pregnancy loss are two of the strongest, independent determinants of pregnancy loss risk. Study design, size, durationThis retrospective cohort study comprises all embryo transfers in Sweden between 2007 and 2022 (n = 202,008). The Swedish Quality Register for Assisted Reproduction (Q-IVF) provides information on confirmed pregnancies from two weeks after embryo transfer. Additional information was retrieved from the Swedish Medical Birth Register and the National Patient Register. Participants/materials, setting, methodsWe studied 202,008 embryo transfers resulting in 80,673 biochemically verified pregnancies and 21,240 pregnancy losses. We assessed the associations between two exposures (maternal age and history of pregnancy loss) and four outcomes (implantation failure, pregnancy loss, the proportion of pregnancy losses occurring within the biochemical pregnancy window, and the gestational duration when the pregnancy loss was diagnosed). Fixed and mixed linear and logistic regression models were used, the latter to account for unmeasured confounding shared across pregnancies from the same mothers. Through analyses of subgroups including oocyte recipients (n = 3,558) and women undergoing treatment due to male infertility (n = 41,721), we attempted to tease out the effects of potential unmeasured confounders, such as maternal oocyte aneuploidies. Main results and the role of chanceMean maternal age was 34 years, 23 % had a history of pregnancy loss, implantation failure occurred after 60 % of embryo transfers and pregnancy loss occurred in 26 % after successful implantation. Higher maternal age was associated with increased risk of implantation failure (OR = 1.02 per year; 95% CI = 1.02, 1.02), and pregnancy loss after successful implantation (OR = 1.05 per year; 95% CI = 1.05, 1.06). We observed no relationship between maternal age and the risk of implantation failure or pregnancy loss among women undergoing ART with donated oocytes. Among those who experienced pregnancy loss, the proportion of pregnancy losses within the biochemical window decreased with increasing maternal age (OR = 0.94 per year; 95% CI = 0.93, 0.94), a result consistent across all subgroups and regardless of oocyte origin. The number of previous pregnancy losses was associated with a lower risk of implantation failure (OR = 0.82; 95% CI = 0.81, 0.84), but not with pregnancy loss in the index pregnancy after accounting for within-women correlations using mixed-effects models (OR = 1.02; 95% CI= 0.99, 1.04). Limitations, reasons for cautionSince all women studied underwent ART treatment, the findings may not apply to naturally conceived pregnancies. The gestational duration of pregnancy losses reflects the time at diagnosis, and thus is an upper bound for the pregnancy loss. Wider implications of the findingsThis study confirms (oocyte) maternal age and history of pregnancy loss as influential in risk of implantation failure and pregnancy loss, and suggests that maternal age may delay the timing of the pregnancy loss, particularly among pregnancy losses occurring within the biochemical pregnancy window. Study funding/competing interest(s)Funding for this research project was granted by the Swedish Research Council; the Swedish Society for Medical Research; the Agreement concerning research and education of doctors; FORTE; Swedish Research Council for Health, Working Life and Welfare; the Hjalmar Svensson Foundation; the Research Council of Norway. The authors declare no conflicts of interest. Trial registration numberN/A
ER -